相关概念视频
Heart Failure Drugs: Diuretics
298
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
298
Dialysis
237
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
237
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
334
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
334
Renal Failure: Dose Adjustments
46
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
46
Antihypertensive Drugs: Potassium-Sparing Diuretics
417
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
417
Hormonal Regulation
32.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K
您也可能阅读
相关文章
通过共同作者、期刊和引用图与本文相关的文章。
排序
Same author
ASN Kidney Health Guidance on Conservative Management in People with Kidney Failure.
Journal of the American Society of Nephrology : JASN·2026
Same author
Creating KidneyPal: A Specialty-Aligned Palliative Care Service for People with Kidney Disease.
Journal of pain and symptom management·2022
相关实验视频
Updated: May 17, 2025

05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
423
对于功能衰竭的保守管理.
1Department of Supportive Oncology, Dana-Farber Cancer Institute, Boston, MA; Division of Renal Medicine, Brigham and Women's Hospital, Boston, MA; Harvard Medical School, Boston, MA.
Advances in kidney disease and health
|April 2, 2025
概括
保守性管理 (CKM) 为功能衰竭提供积极的医疗护理,不需要透析. 这种方法优先考虑通过保护功能和有效管理症状来提高生活质量.
更多相关视频
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 老年病的医生 老年病的医生
- 抚慰性护理是一种缓解性护理.
背景情况:
- 功能衰竭需要治疗决策,包括透析或保守管理.
- 保守性管理 (CKM) 是治疗末期病时透析的替代方案.
- CKM重点关注症状控制和生活质量.
研究的目的:
- 将保守性管理 (CKM) 定义为对衰竭的积极方法.
- 要突出CKM的目标:维护功能和提高生活质量.
- 在CKM下概述与功能衰竭相关的症状的医疗管理.
主要方法:
- CKM涉及到积极的医疗监测和干预.
- 它强调症状评估和管理.
- 保存剩余的功能是一个关键的目标.
主要成果:
- CKM旨在优化患者的生活质量.
- 它的重点是推迟或避免透析.
- 实现了对功能衰竭症状的有效医疗管理.
结论:
- 保守性管理是衰竭的可行选择.
- 医疗康复医院优先考虑患者的福祉和生活质量.
- 积极的医疗管理是成功的CKM的核心.

